Osteoporosis is a debilitating disease that affects millions of people worldwide. Current
osteoporosis treatments are predominantly bone-resorbing drugs that are associated with …

Osteoporosis is a systemic disease that affects the skeleton, causing reduction of bone
density and mass, resulting in destruction of bone microstructure and increased risk of bone …

Osteoporosis, or bone loss, is a progressive, systemic skeletal disease that affects millions of
people worldwide. Osteoporosis is generally age related, and it is underdiagnosed because …

Osteoporosis (OP), a common systemic metabolic bone disease, is characterized by low
bone mass, increasing bone fragility and a high risk of fracture. At present, the clinical …

Prospects for osteoprogenitor stem cells in fracture repair... : Current Opinion in Organ
Transplantation Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis …

Osteoporosis is a systemic skeletal disease associated with reduced bone strong point that
results in raised fracture risk, with decreased bone strength, leading to reduced bone …

Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and
microstructural degeneration. The personal and societal costs of osteoporosis are …

Bone marrow is a reservoir of pluripotent stem/progenitor cells for mesenchymal tissues.
Upon in vitro expansion, in vivo bone-forming efficiency of bone marrow stromal cells …

Mesenchymal stem cells (MSC) originate from bone marrow and give rise to various cell
types, including osteoblasts, chondrocytes, adipocytes, and myocytes. Lineage-specific …

The field of cell therapy and regenerative medicine can hold the promise of restoring normal
tissues structure and function. Additionally, the main targets of stem cell-based therapies are …